The CELG chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CELG chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CELG stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CELG Detailed Price Forecast - CNN Money||View CELG Detailed Summary - Google Finance|
|View CELG Detailed Summary - Yahoo! Finance||View CELG Stock Research & Analysis - Zacks.com|
|View CELG Trends & Analysis - Trade-Ideas||View CELG Major Holders - Barrons|
|View CELG Call Transcripts - NASDAQ||View CELG Breaking News & Analysis - Seeking Alpha|
|View CELG Annual Report - CompanySpotlight.com||View CELG OTC Short Report - OTCShortReport.com|
|View CELG Fundamentals - TradeKing||View CELG SEC Filings - Bar Chart|
|View Historical Prices for CELG - The WSJ||View Performance/Total Return for CELG - Morningstar|
|View the Analyst Estimates for CELG - MarketWatch||View the Earnings History for CELG - CNBC|
|View the CELG Earnings - StockMarketWatch||View CELG Buy or Sell Recommendations - MacroAxis|
|View the CELG Bullish Patterns - American Bulls||View CELG Short Pain Metrics - ShortPainBot.com|
|View CELG Stock Mentions - StockTwits||View CELG Stock Mentions - PennyStockTweets|
|View CELG Stock Mentions - Twitter||View CELG Investment Forum News - Investor Hub|
|View CELG Stock Mentions - Yahoo! Message Board||View CELG Stock Mentions - Seeking Alpha|
|View Insider Transactions for CELG - SECform4.com||View Insider Transactions for CELG - Insider Cow|
|View CELG Major Holdings Summary - CNBC||View Insider Disclosure for CELG - OTC Markets|
|View Insider Transactions for CELG - Yahoo! Finance||View Institutional Holdings for CELG - NASDAQ|
|View CELG Stock Insight & Charts - FinViz.com||View CELG Investment Charts - StockCharts.com|
|View CELG Stock Overview & Charts - BarChart||View CELG User Generated Charts - Trading View|
3 Best Big Pharma Stocks to Buy for the 2nd Half of 2018
Posted on Sunday July 15, 2018
Forget what's happened so far in 2018. These big pharma stocks look like great picks for the rest of the year.
Why Celgene Corporation Lost 23.9% of Its Value Halfway Through 2018
Posted on Friday July 13, 2018
Celgene's self-inflicted wounds haven't sat well with investors this year.
Biotech Celgene's Stock Seen Rebounding 14%
Posted on Friday July 13, 2018
Celgene Corp.'s ( CELG) stock appears to be on the mend, after falling by more than 40% since the middle of October. The biotech company has been working hard in 2018 trying the turn the corner, by making two big acquisitions, helping to strengthen the pipeline. Analysts still see robust growth for the stock, while it also happens to be trading at its lowest valuation since 2015.
Ex-Drug CEO Running for Senate Seat Attacked by Old Industry Foe
Posted on Thursday July 12, 2018
A patient-advocacy group opposed to high drug prices says it will spend $1.5 million on ads attacking New Jersey GOP Senate candidate Bob Hugin, the former chief executive of drugmaker Celgene Corp. The advocacy group, Patients for Affordable Drugs Action, says the anti-Hugin ads that will run in the state are the first of millions of dollars worth of in political advertising it will use to target candidates it says are responsible for high drug prices. In 2007, when Hugin was chief operating officer, a 10-milligram dose of the company’s blockbuster cancer pill Revlimid cost $247.28, according to data from Connecture Inc. Over the next decade, Celgene raised its price more than a dozen times as Hugin became chief executive officer and eventually executive chairman.